EFFICACY AND SAFETY OF UPADACITINIB FOR ATOPIC DERMATITIS IN DUPILUMAB NON-RESPONDERS: A MULTICENTER RETROSPECTIVE STUDY

被引：0
|
作者：
Georgakopoulos, Jorge R. [1 ]
Sheka, Dropen [2 ]
Rankin, Brian [3 ]
Maliyar, Khalad [1 ]
Rimke, Alexander [4 ]
Prajapati, Vimal H. [3 ]
Yeung, Jensen [1 ]
机构：
[1] Univ Toronto, Div Dermatol, Dept Med, Toronto, ON, Canada
[2] Univ Toronto, Fac Med, Toronto, ON, Canada
[3] Univ Calgary, Div Dermatol, Dept Med, Calgary, AB, Canada
[4] Dermatol Res Inst, Calgary, AB, Canada
来源：
ACTA DERMATO-VENEREOLOGICA | 2023年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
OL.12
引用
收藏
页码：16 / 16
页数：1
相关论文
共 50 条
  • [41] Reanalysis Following Removal of Participants From 1 Site in Multicenter Trial of Upadacitinib vs Dupilumab for Atopic Dermatitis
    Blauvelt, Andrew
    JAMA DERMATOLOGY, 2024, 160 (03) : 319 - 319
  • [42] Effectiveness and safety of upadacitinib retreatment after withdrawal in moderate-to-severe atopic dermatitis: a retrospective study
    Hagino, Teppei
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024,
  • [43] A 52 WEEKS RETROSPECTIVE STUDY OF DUPILUMAB TREATMENT FOR MODERATE TO SEVERE ATOPIC DERMATITIS IN KOREA: LONG-TERM EFFICACY AND SAFETY OF DUPILUMAB IN REAL WORLD PRACTICE
    Ahn, Jiyoung
    Jang, Dong Hyek
    Heo, Seok Jae
    Lee, Dong Heon
    Jung, Hye Jung
    Park, Mi Yeon
    Seo, Seoung Jun
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 13 - 13
  • [44] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
    Zheng, Y.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 72 - 72
  • [45] Efficacy, Safety, and Early Relapse After Cessation of Upadacitinib Versus Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Real-World Study in China
    Zhu, Jiling
    Wu, Hanwen
    Ye, Yahui
    Xu, Qiuyang
    Shao, Junyi
    Bai, Zicheng
    Zhou, Yiwen
    Li, Zhenyan
    Liu, Jingjing
    Li, Zhiming
    DERMATITIS, 2024, 35 (06) : 636 - 645
  • [46] Clinical efficacy and safety of Dupilumab for the treatment of moderate to severe atopic dermatitis in Korea
    Kim, Jongwook
    Kim, Yeona
    Won, Sang-Hyeon
    Bae, Kyung-Nam
    Lee, Jungsoo
    Shin, Kihyuk
    Kim, Hoonsoo
    Ko, Hyunchang
    Kim, Moon-Bum
    Kim, Byungsoo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB136 - AB136
  • [47] Dupilumab efficacy in different atopic dermatitis phenotypes
    Brancaccio, R.
    Florio, G.
    Peduto, T.
    Patella, V
    ALLERGY, 2020, 75 : 442 - 442
  • [48] Efficacy of dupilumab in moderate and severe atopic dermatitis
    Weidinger, Stephan
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Schmitt, Jochen
    Leshem, Yael A.
    Katoh, Norito
    Chen, Zhen
    Zhang, Haixin
    Shumel, Brad
    Bansal, Ashish
    Chao, Jingdong
    Lu, Yufang
    Rossi, Ana B.
    Abramova, Alvina
    JEADV CLINICAL PRACTICE, 2023, 2 (02): : 247 - 260
  • [49] EFFICACY AND SAFETY OF DUPILUMAB IN PRESCHOOL CHILDREN WITH ATOPIC DERMATITIS AND TYPE 2 COMORBIDITIES
    Boguniewicz, M.
    Sher, L.
    Paller, A.
    Chen, Z.
    Shah, P.
    Marco, A. Rodriguez
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S47 - S47
  • [50] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
    Xu, Xinghua
    Zheng, Yi
    Zhang, Xin
    He, Yanling
    Li, Chengxin
    ONCOTARGET, 2017, 8 (65) : 108480 - 108491
12345